Distribution of Dengue Serotypes in Argentina in the Last 2 Years
DOI:
https://doi.org/10.62486/agmu202557Keywords:
Dengue, Dengue Virus, Aedes, Argentina, Disease Vector ControlAbstract
Introduction: dengue virus is transmitted mainly by the Aedes aegypti mosquito, and represents a public health problem worldwide, especially in tropical and subtropical regions.
Objective: to determine the dengue serotypes circulating in Argentina.
Methods: Epidemiological reports were evaluated retrospectively. Dengue surveillance data from the National Ministry of Health of the Argentine Republic during the period 2022 to 2024 were used for this purpose.
Results: the serotypes circulating in Argentina during 2022-2023 were DenV-1 and DenV-2; during the 2024 outbreak, the DenV-3 serotype was introduced, with DenV-2 accounting for 57,41 %, DenV-1 for 42,40 % and DenV-3 for 0,19 %.
Conclusion: the predominance of serotypes DENV-1 and DENV-2, and the introduction of serotype DENV-3 in 2024, increase the risk of sequential infections and severe forms of the disease, which emphasizes the need to implement effective strategies, between endemic and epidemic years, for vector control and to promote community awareness
References
Viegas M, et al. Dengue Virus 1 Outbreak in Buenos Aires, Argentina, 2016. Emerg Infect Dis. octubre de 2017;23(10):1684-5. DOI: https://doi.org/10.3201/eid2310.161718
Carbajo AE, Schweigmann N, Curto SI, De Garín A, Bejarán R. Dengue transmission risk maps of Argentina. Trop Med Int Health. marzo de 2001;6(3):170-83. DOI: https://doi.org/10.1046/j.1365-3156.2001.00693.x
Barrero PR, Mistchenko AS. Genetic analysis of Dengue virus type 3 isolated in Buenos Aires, Argentina. Virus Res. julio de 2008;135(1):83-8. DOI: https://doi.org/10.1016/j.virusres.2008.02.013
Wilder-Smith A, Murray, Quam M. Epidemiology of dengue: past, present and future prospects. Clin Epidemiol. agosto de 2013;299. DOI: https://doi.org/10.2147/CLEP.S34440
Boletin epidemio Argentina.pdf.
Vezzani D, Carbajo AE. Aedes aegypti, Aedes albopictus, and dengue in Argentina: current knowledge and future directions. Mem Inst Oswaldo Cruz. 31 de enero de 2008;103(1):66-74. DOI: https://doi.org/10.1590/S0074-02762008005000003
Dengue: guías para la atención de enfermos en la región de las Américas. Segunda edición. Washington, USA.: Organización Panamericana de la Salud, Oficina Sanitaria Panamericana : Oficina Regional de la Organización Mundial de la Salud; 2016.
Shepard DS, Undurraga EA, Halasa YA, Stanaway JD. The global economic burden of dengue: a systematic analysis. Lancet Infect Dis. agosto de 2016;16(8):935-41. DOI: https://doi.org/10.1016/S1473-3099(16)00146-8
Byrne AB, Gutierrez GF, Bruno A, Córdoba MT, Bono MM, Polack FP, et al. Age‐associated differences in clinical manifestations and laboratory parameters during a dengue virus type 4 outbreak in Argentina. J Med Virol. febrero de 2018;90(2):197-203. DOI: https://doi.org/10.1002/jmv.24952
Porcasi X, Rotela CH, Introini MV, Frutos N, Lanfri S, Peralta G, et al. An operative dengue risk stratification system in Argentina based on geospatial technology. Geospatial Health. 1 de septiembre de 2012;6(3):31. DOI: https://doi.org/10.4081/gh.2012.120
Katzelnick LC, Gresh L, Halloran ME, Mercado JC, Kuan G, Gordon A, et al. Antibody-dependent enhancement of severe dengue disease in humans. Science. 17 de noviembre de 2017;358(6365):929-32. DOI: https://doi.org/10.1126/science.aan6836
Wilder-Smith A, Ooi EE, Vasudevan SG, Gubler DJ. Update on Dengue: Epidemiology, Virus Evolution, Antiviral Drugs, and Vaccine Development. Curr Infect Dis Rep. mayo de 2010;12(3):157-64. DOI: https://doi.org/10.1007/s11908-010-0102-7
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Mercedes Pablo Araujo, Susana Carnovale (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.
